The February 5, 2019 letter to Commissioner Scott Gottlieb highlights the value of evidence-based home safe-disposal strategies and encourages the FDA to implement them through the recently-enacted Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act.
